Glucocorticoids for ARDS: Just do it!

Chest

Volumn 131, Issue 4, 2007, Pages 945-946

  Annane, Djillali ^a,b,c,d  

^a RAYMOND POINCARÉ HOSPITAL   (France)

^b Department of Medicine ^*  (France)

^c General Intensive Care Unit   (France)

^d LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; METHYLPREDNISOLONE; NEUROMUSCULAR BLOCKING AGENT;

ADULT RESPIRATORY DISTRESS SYNDROME; DRUG EFFICACY; DRUG MEGADOSE; EDITORIAL; FEVER; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPERGLYCEMIA; INFLAMMATION; LOW DRUG DOSE; LUNG INJURY; MUSCLE WEAKNESS; PRIORITY JOURNAL; SUPERINFECTION; SURVIVAL;

EID: 34247209764     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.06-3005     Document Type: Editorial

References (16)

1. Brun Buisson C, Minelli C, Bertolini G, et al. Epidemiology and outcome of acute lung injury in European intensive care units: results from the ALIVE study. Intensive Care Med 2004; 30:51-61
2. Matthay MA, Zimmerman GA, Esmon C, et al. Future research directions in acute lung injury: summary of a national heart, lung, and blood institute working group. Am J Respir Crit Care Med 2003; 167:1027-1035
3. Meduri GU, Muthiah MP, Carratu P, et al. Nuclear factor-κB- and glucocorticoid receptor α-mediated mechanisms in the regulation of systemic and pulmonary inflammation during sepsis and acute respiratory distress syndrome: evidence for inflammation-induced target tissue resistance to glucocorticoids. Neuroimmunomodulation 2005; 12:321-338
4. The ARDS-Network. Ventilation with lower tidal volume as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342:1301-1308
5. Weigelt JA, Norcross JF, Borman KR, et al. Early steroid therapy for respiratory failure. Arch Surg 1985; 120:536-540
6. Bone RC, Fischer CJ Jr, Clemmer TP, et al. Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome. Chest 1987; 92:1032-1036
7. Bernard GR, Luce JL, Sprung CL, et al. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med 1987; 317:156.5-1570
8. Luce JM, Montgomery AB, Marks JD, et al. Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis 1988; 138:62-68
9. Chadda K, Annane D. The use of corticosteroids in severe sepsis and acute respiratory distress syndrome. Ann Med 2002; 34:582-589
10. Meduri GU, Tolley EA, Chrousos GP, et al. Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids. Am J Respir Crit Care Med 2002; 165:983-991
11. Meduri GU, Headley AS, Golden E, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 1998; 280:159-165
12. Annane D, Sébille V, Bellissant E, et al. Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome. Crit Care Med 2006; 34:22-30
13. Steinberg KP, Hudson LD, Goodman RB, et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 42 2006; 354:1671-1684
14. Meduri GU, Golden E, Freire A, et al. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest 2007; 131:954-963
15. Rocco PR, Souza AB, Faffe DS, et al. Effect of corticosteroid on lung parenchyma remodeling at an early phase of acute lung injury. Am J Respir Crit Care Med 2003; 168:677-684
16. Confalonieri M, Urbino R, Potena A, et al. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med 2005; 171:242-248